Cargando…
What does not kill you makes you stronger: surviving anti-cancer therapies by cytoskeletal remodeling and Myosin II reactivation
Myosin II and its regulator Rho-associated coiled-coil containing protein kinase (ROCK) are essential for cell invasion and metastatic dissemination. Our recent findings show that this molecular machinery is also involved in drug resistance in melanoma by playing a dual role: protection of tumor cel...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199747/ https://www.ncbi.nlm.nih.gov/pubmed/32391428 http://dx.doi.org/10.1080/23723556.2020.1735911 |
_version_ | 1783529207042670592 |
---|---|
author | Orgaz, Jose L Sanz-Moreno, Victoria |
author_facet | Orgaz, Jose L Sanz-Moreno, Victoria |
author_sort | Orgaz, Jose L |
collection | PubMed |
description | Myosin II and its regulator Rho-associated coiled-coil containing protein kinase (ROCK) are essential for cell invasion and metastatic dissemination. Our recent findings show that this molecular machinery is also involved in drug resistance in melanoma by playing a dual role: protection of tumor cells from reactive oxygen species (ROS) and DNA damage (intrinsic), and co-option of myeloid and lymphoid populations to establish immunosuppression (extrinsic). |
format | Online Article Text |
id | pubmed-7199747 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-71997472020-09-28 What does not kill you makes you stronger: surviving anti-cancer therapies by cytoskeletal remodeling and Myosin II reactivation Orgaz, Jose L Sanz-Moreno, Victoria Mol Cell Oncol Author's Views Myosin II and its regulator Rho-associated coiled-coil containing protein kinase (ROCK) are essential for cell invasion and metastatic dissemination. Our recent findings show that this molecular machinery is also involved in drug resistance in melanoma by playing a dual role: protection of tumor cells from reactive oxygen species (ROS) and DNA damage (intrinsic), and co-option of myeloid and lymphoid populations to establish immunosuppression (extrinsic). Taylor & Francis 2020-03-26 /pmc/articles/PMC7199747/ /pubmed/32391428 http://dx.doi.org/10.1080/23723556.2020.1735911 Text en © 2020 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Author's Views Orgaz, Jose L Sanz-Moreno, Victoria What does not kill you makes you stronger: surviving anti-cancer therapies by cytoskeletal remodeling and Myosin II reactivation |
title | What does not kill you makes you stronger: surviving anti-cancer therapies by cytoskeletal remodeling and Myosin II reactivation |
title_full | What does not kill you makes you stronger: surviving anti-cancer therapies by cytoskeletal remodeling and Myosin II reactivation |
title_fullStr | What does not kill you makes you stronger: surviving anti-cancer therapies by cytoskeletal remodeling and Myosin II reactivation |
title_full_unstemmed | What does not kill you makes you stronger: surviving anti-cancer therapies by cytoskeletal remodeling and Myosin II reactivation |
title_short | What does not kill you makes you stronger: surviving anti-cancer therapies by cytoskeletal remodeling and Myosin II reactivation |
title_sort | what does not kill you makes you stronger: surviving anti-cancer therapies by cytoskeletal remodeling and myosin ii reactivation |
topic | Author's Views |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199747/ https://www.ncbi.nlm.nih.gov/pubmed/32391428 http://dx.doi.org/10.1080/23723556.2020.1735911 |
work_keys_str_mv | AT orgazjosel whatdoesnotkillyoumakesyoustrongersurvivinganticancertherapiesbycytoskeletalremodelingandmyosiniireactivation AT sanzmorenovictoria whatdoesnotkillyoumakesyoustrongersurvivinganticancertherapiesbycytoskeletalremodelingandmyosiniireactivation |